Dr. He Ruyi, Chief Medical Officer of the company, is an authoritative expert in the field of clinical drug development and global regulatory systems in China. Dr. He Ruyi has worked in the FDA of US, and NMPA, China for almost 20 years, including over 17 years in the FDA. He has held multiple strategic leadership positions and participated in the formulation of FDA guidelines in multiple therapeutic areas. While serving as the chief scientist of the Center for Drug Evaluation (CDE) of NMPA, China, he promoted a number of drug administration reforms. Dr. He Ruyi has published more than 20 research papers and abstracts in the fields of drug regulatory science and internal medicine. He received his bachelor’s and master’s degrees in medicine from China Medical University and his doctorate in internal medicine from Howard University in the US. He is a certified practicing physician in the US.